ADcure
-
Posts
9 -
Joined
-
Last visited
Content Type
Profiles
Forums
Events
Posts posted by ADcure
-
-
Lady I know was diagnosed w/ early on-set AD in 2011 (age 62) and was in Tau Rx trials since then and has actually improved mentally overall. Granted, that is just 1 case, but----
-
One needs to read FULLY the results of TauRx trials before recommending fire sale of that asset.
-
Would that investor be Genting or someone else?
Thanks
-
2 things about Taurx's drug, #1 it was given "orphan drug status" by FDA for some dementia. #2 if one reads the complete results of last phase 3 trial it becomes apparent that the drug does have a lot of merit, even surprising the folks at Taurx, thus the new trial Lucidty.
-
I believe that sale of Taurx prior to IPO would be a monumental mistake.
-
To safety in numbers, Anyone else involved?
Yes
-
Just read rcfunds report. Am I missing something? If Dundee has a market cap of $70 million, and marketable securities of $162 million, why doesn't someone buy Dundee and sell/liquidate it, double their money, and put it out of its misery?
-
With cash on hand of about 40M and annual needs of about 59M, how long do you think till they hit zero, seriously?
Thanks for your thoughts
Dumbdee - The Goodmans, The Bad & The Ugly - 30% of NAV bargain?
in General Discussion
Posted
The upside potential of taurx will be measured in the billions, not millions. The risk/reward for Dundee, warrants hanging on to taurx. If they want to sell, I would be a buyer for a few shares, even tho I don't have millions.